UK bio pharma : Innovation re invention and capital at risk
Haslam, Colin, Tsitsianis, N. and Gleadle, Pauline
(2011)
UK bio pharma : Innovation re invention and capital at risk.
UNSPECIFIED.
Institute of Chartered Accountants of Scotland.
Small and medium enterprise (SME) bio-pharmas play a significant role in the development of a knowledge-based competitive economy because they act as an incubator of creativity for the development of pharmabased products which they steer towards regulatory approval. Their contribution is predominantly the development of new pharmaceutical products which can then be licensed or sold on to big-pharma.
| Item Type | Monograph (UNSPECIFIED) |
|---|---|
| Date Deposited | 26 Jul 2024 13:53 |
| Last Modified | 26 Jul 2024 13:53 |
Downloads
Full text not available from this repository.
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
- Department of Accounting, Finance and Economics
- Social Sciences, Arts & Humanities Research Institute
- Finance and Accounting Research Unit
- Centre for Research on Management, Economy and Society
- Hertfordshire Business School
Find other related resources:
- http://icas.org.uk/haslam/ [error in script]